In ovarian cancer cells, treatment with the PARP inhibitor Olaparib can trigger ferroptotic death through the suppression of light chain subunit solute carrier family 7 member 11 (SLC7A11)-mediated GSH biosynthesis [19]. This evidence concerns the gene SLC7A11 and ovarian carcinoma.